Design
Review
Authors
Loading...
Supports targeted trials in hypertension and heart failure; review-level data leaves clinical adoption open.
Endothelin receptor antagonists have been developed and show therapeutic potential in animal models and human patients with chronic cardiovascular diseases such as hypertension, pulmonary hypertension, and heart failure.
Katsutoshi Goto (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: